Literature DB >> 17498694

GFAP and its role in Alexander disease.

Roy A Quinlan1, Michael Brenner, James E Goldman, Albee Messing.   

Abstract

Here we review how GFAP mutations cause Alexander disease. The current data suggest that a combination of events cause the disease. These include: (i) the accumulation of GFAP and the formation of characteristic aggregates, called Rosenthal fibers, (ii) the sequestration of the protein chaperones alpha B-crystallin and HSP27 into Rosenthal fibers, and (iii) the activation of both Jnk and the stress response. These then set in motion events that lead to Alexander disease. We discuss parallels with other intermediate filament diseases and assess potential therapies as part of this review as well as emerging trends in disease diagnosis and other aspects concerning GFAP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498694      PMCID: PMC2702672          DOI: 10.1016/j.yexcr.2007.04.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  81 in total

1.  Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C.

Authors:  F Lin; H J Worman
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

2.  Coordinate and independent regulation of alpha B-crystallin and hsp27 expression in response to physiological stress.

Authors:  M W Head; E Corbin; J E Goldman
Journal:  J Cell Physiol       Date:  1994-04       Impact factor: 6.384

3.  Detection of the peripheral nervous system (PNS)-type glial fibrillary acidic protein (GFAP) and its mRNA in human lymphocytes.

Authors:  H Riol; M Tardy; B Rolland; G Lévesque; M R Murthy
Journal:  J Neurosci Res       Date:  1997-04-01       Impact factor: 4.164

4.  Glial fibrillary acidic protein mRNA isotypes: expression in vitro and in vivo.

Authors:  E Galea; P Dupouey; D L Feinstein
Journal:  J Neurosci Res       Date:  1995-07-01       Impact factor: 4.164

5.  Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice.

Authors:  K Furukawa; H Inagaki; Y Hotta
Journal:  Exp Cell Res       Date:  1994-06       Impact factor: 3.905

6.  Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts.

Authors:  P Mehlen; X Preville; P Chareyron; J Briolay; R Klemenz; A P Arrigo
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

7.  An alternative splicing product of the lamin A/C gene lacks exon 10.

Authors:  B M Machiels; A H Zorenc; J M Endert; H J Kuijpers; G J van Eys; F C Ramaekers; J L Broers
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

8.  Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease.

Authors:  M W Head; E Corbin; J E Goldman
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  A novel glial fibrillary acidic protein mRNA lacking exon 1.

Authors:  D Zelenika; B Grima; M Brenner; B Pessac
Journal:  Brain Res Mol Brain Res       Date:  1995-06

10.  Sense and antisense modification of glial alpha B-crystallin production results in alterations of stress fiber formation and thermoresistance.

Authors:  T Iwaki; A Iwaki; J Tateishi; J E Goldman
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

View more
  69 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  Late onset Alexander's disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene.

Authors:  Stephan Schmidt; Mike P Wattjes; Wanda M Gerding; Marjo van der Knaap
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

Review 3.  Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function.

Authors:  Jason Lowery; Edward R Kuczmarski; Harald Herrmann; Robert D Goldman
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

Review 4.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

5.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

6.  Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.

Authors:  Jinte Middeldorp; Willem Kamphuis; Jacqueline A Sluijs; Dalila Achoui; Cathalijn H C Leenaars; Matthijs G P Feenstra; Paula van Tijn; David F Fischer; Celia Berkers; Huib Ovaa; Roy A Quinlan; Elly M Hol
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

Review 7.  PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.

Authors:  Mario Vallejo
Journal:  Mol Neurobiol       Date:  2009-02-24       Impact factor: 5.590

8.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

9.  Can MR imaging diagnose adult-onset Alexander disease?

Authors:  L Farina; D Pareyson; L Minati; I Ceccherini; L Chiapparini; S Romano; P Gambaro; R Fancellu; M Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

Review 10.  Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders.

Authors:  Serena Carra; Paola Rusmini; Valeria Crippa; Elisa Giorgetti; Alessandra Boncoraglio; Riccardo Cristofani; Maximillian Naujock; Melanie Meister; Melania Minoia; Harm H Kampinga; Angelo Poletti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-03-25       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.